Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.

Background: Doxorubicin (Dox) is a widely used chemotherapy, but its effectiveness is limited by dose-dependent side effects. Although lower Dox doses reduce this risk, studies have reported higher recurrence of local disease with no improvement in survival rate in patients receiving low doses of Do...

Descripción completa

Detalles Bibliográficos

Publicado en:	Breast Cancer Research Vol. 23; no. 1; pp. 1 - 21
Autores principales:	Mohammed, Samia, Shamseddine, Achraf A., Newcomb, Benjamin, Chavez, Ronald S., Panzner, Tyler D., Lee, Allen H., Canals, Daniel, Okeoma, Chioma M., Clarke, Christopher J., Hannun, Yusuf A.
Formato:	research Journal Article
Publicado:	BioMed Central 7/27/2021
Acceso en línea:	Ver este registro en EBSCOhost